MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...

Hologic is putting down about $310 million to acquire Endomagnetics, the developer of technologies for localizing tumors in breast cancer surgeries without using radioactive materials. Also known as ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Hologic Inc. moved to expand its breast surgery line with the acquisition of Endomagnetics Ltd. (Endomag) for a proposed $310 million. Endomag offers a magnetic system that allows precise localization ...

Hologic Inc has acquired Somatex Medical Technologies, a provider of biopsy site markers and localization technologies, for approximately $64 million. The company was previously owned by E-Med ...

Leader in Women’s Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Experience the cutting-edge Envision™ Mammography Platform (Graphic: ...

Hologic HOLX is a long-standing innovator in developing and advancing technologies to help detect and treat breast cancer. The Massachusetts-based MedTech firm rang the Nasdaq opening bell for the ...